Related Experiment Video

Updated: Jun 22, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Targeting RhoA/Rho kinase and p21-activated kinase signaling to prevent cancer development and progression

Yu-Wen E Chang1, Ronald R Bean, Rolf Jakobi

  • 1Kansas City University of Medicine and Biosciences, Kansas City, MO 64106-1453, USA. echang@kcumb.edu

Recent Patents on Anti-Cancer Drug Discovery
|June 13, 2009
PubMed

Insights

RhoA/Rho kinase and p21-activated kinase signaling promote cancer development and metastasis. Targeting these pathways offers potential for novel anti-cancer therapies to inhibit tumor progression and spread.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Aberrant RhoA/Rho kinase and p21-activated kinase signaling are implicated in cancer progression.
  • These pathways regulate critical cellular processes including invasion, motility, survival, and growth.
  • Disruption of cell-cell adhesion and extracellular matrix degradation are key mechanisms driven by these signaling pathways.

Purpose of the Study:

  • To review the normal functions of RhoA/Rho kinase and p21-activated kinase signaling.
  • To elucidate mechanisms of pathway activation in cancer.
  • To discuss the role of these pathways in cancer development, metastasis, and therapeutic targeting.

Main Methods:

  • Literature review of RhoA/Rho kinase and p21-activated kinase signaling in cancer.
  • Analysis of mechanisms driving constitutive pathway activation.
  • Summary of patents related to therapeutic targeting of these pathways.

Main Results:

  • Constitutive activation of RhoA/Rho kinase and p21-activated kinase pathways drives cancer cell invasion and metastasis.
  • These activated pathways contribute to aggressive phenotypes and reduced patient outcomes.
  • Numerous patents highlight the therapeutic potential of targeting these signaling cascades.

Conclusions:

  • RhoA/Rho kinase and p21-activated kinase are critical regulators of cancer progression and metastasis.
  • Targeting these pathways represents a promising strategy for developing new anti-cancer therapies.
  • Further research and clinical development are warranted to explore the full potential of modulating these signaling pathways.

More Related Videos

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...